An observational study in Inpatient Endoscopy Delay, Readmission and Prolonged Hospital Stay, sponsored by Radboud University Medical Center. Not yet recruiting at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-21.
Sponsored by Radboud University Medical Center · Observational
Single center retrospective cohort study of all inpatient endoscopy procedures to asses factors associated with inpatient endoscopy delays and impact on length of stay and 30-day readmission
Background: Delays in inpatient endoscopy planning negatively influence the quality and accessibility of care. This may result in higher healthcare costs, negative health outcomes, and unnecessary readmissions and use of hospital beds. Additionally, prolonged hospital stay is associated with poorer health outcomes and risk of nosocomial infections, amongst others.
Objective: To asses factors associated with inpatient endoscopy delays and impact on length of stay and 30-day readmission
Study design: Single center retrospective cohort study of all inpatient endoscopy procedures (gastroscopy, colonoscopy, ERCP, sigmoidoscopy) during 2016-2022. Data will be identified and extracted using CTCue. Only pseudonymized data will be used. Inpatient endoscopy delay will be defined as the number of days between the planned date versus the actual date. Multivariable logistic regression models will be performed to assess factors associated with inpatient endoscopy delay.
Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult inpatients from all hospital departments undergoing endoscopy procedures. Patients will be selected via CTCue, with an admission based query that selects all adult patients with an admission of at least two days between 1-1-2014 and 1-12-2022 AND an endoscopic care activity.
Exclusion Criteria:
all inpatient endoscopy procedures (gastroscopy, colonoscopy, ERCP, sigmoidoscopy) during 2016-2022.
Rate of inpatient endoscopy delays (IED)
IED will be defined as the number of days between the planned date versus the actual date.
Time frame: at endoscopic procedure
Difference in type of endoscopic procedure between patients with and without IED
Type of endoscopic procedure: gastroscopy/colonoscopy/endoscopic retrograde cholangio-pancreaticography (ERCP)
Time frame: at endoscopic procedure
Difference in type of sedation between patients with and without IED
Type of sedation during endoscopic procedure: No sedation/conscious sedation/general anesthesia
Time frame: at endoscopic procedure
Median length of hospital stay
length of hospital admission in days
Time frame: through study cohort period from 1 january 2016 until 31 december 2022
rate of 30-day readmissions
percentage of readmissions within 30 days after initial discharge
Time frame: up to 30 days
Odds ratio of presence of inpatient endoscopy delays for risk of prolonged length of hospital stay and 30-day readmissions
multivariable logistic regression modelling to assess factors associated with both outcomes and the impact of inpatient endoscopy delay
Time frame: from admission till 30 days after discharge
Odds ratio of presence of inpatient endoscopy delays for risk of 30-day readmissions
multivariable logistic regression modelling to assess factors associated with both outcomes and the impact of inpatient endoscopy delay
Time frame: from admission till 30 days after discharge
Plan to share: Yes — IPD will be shared upon reasonable request
Supporting information: Study protocol, Sap, Csr, Analytic code
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Radboud University Medical Center